Myeloperoxidase-mediated solution demonstrates rapid virucidal properties against the delta variant of SARS-CoV-2

Detalles Bibliográficos
Autores principales: Denys, G.A., Burningham, K., Dyba, J., Allen, R.C., Stephens, J.T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Healthcare Infection Society. Published by Elsevier Ltd. 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864890/
https://www.ncbi.nlm.nih.gov/pubmed/35218796
http://dx.doi.org/10.1016/j.jhin.2022.02.013
_version_ 1784655543930978304
author Denys, G.A.
Burningham, K.
Dyba, J.
Allen, R.C.
Stephens, J.T.
author_facet Denys, G.A.
Burningham, K.
Dyba, J.
Allen, R.C.
Stephens, J.T.
author_sort Denys, G.A.
collection PubMed
description
format Online
Article
Text
id pubmed-8864890
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Healthcare Infection Society. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-88648902022-02-24 Myeloperoxidase-mediated solution demonstrates rapid virucidal properties against the delta variant of SARS-CoV-2 Denys, G.A. Burningham, K. Dyba, J. Allen, R.C. Stephens, J.T. J Hosp Infect Letter to the Editor The Healthcare Infection Society. Published by Elsevier Ltd. 2022-05 2022-02-23 /pmc/articles/PMC8864890/ /pubmed/35218796 http://dx.doi.org/10.1016/j.jhin.2022.02.013 Text en © 2022 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Denys, G.A.
Burningham, K.
Dyba, J.
Allen, R.C.
Stephens, J.T.
Myeloperoxidase-mediated solution demonstrates rapid virucidal properties against the delta variant of SARS-CoV-2
title Myeloperoxidase-mediated solution demonstrates rapid virucidal properties against the delta variant of SARS-CoV-2
title_full Myeloperoxidase-mediated solution demonstrates rapid virucidal properties against the delta variant of SARS-CoV-2
title_fullStr Myeloperoxidase-mediated solution demonstrates rapid virucidal properties against the delta variant of SARS-CoV-2
title_full_unstemmed Myeloperoxidase-mediated solution demonstrates rapid virucidal properties against the delta variant of SARS-CoV-2
title_short Myeloperoxidase-mediated solution demonstrates rapid virucidal properties against the delta variant of SARS-CoV-2
title_sort myeloperoxidase-mediated solution demonstrates rapid virucidal properties against the delta variant of sars-cov-2
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864890/
https://www.ncbi.nlm.nih.gov/pubmed/35218796
http://dx.doi.org/10.1016/j.jhin.2022.02.013
work_keys_str_mv AT denysga myeloperoxidasemediatedsolutiondemonstratesrapidvirucidalpropertiesagainstthedeltavariantofsarscov2
AT burninghamk myeloperoxidasemediatedsolutiondemonstratesrapidvirucidalpropertiesagainstthedeltavariantofsarscov2
AT dybaj myeloperoxidasemediatedsolutiondemonstratesrapidvirucidalpropertiesagainstthedeltavariantofsarscov2
AT allenrc myeloperoxidasemediatedsolutiondemonstratesrapidvirucidalpropertiesagainstthedeltavariantofsarscov2
AT stephensjt myeloperoxidasemediatedsolutiondemonstratesrapidvirucidalpropertiesagainstthedeltavariantofsarscov2

Ejemplares similares